Table 2.

Clinical details of patients with PR to VSTs

Patient with PRThird-party or donor-derived VSTNo. of infusionsDetails of PR
Third-party Viremia improved from 4400 to <100 copies per mL 
Third-party Viremia improved from 1 million to 7135 copies per mL after first infusion; no further decrease with second infusion 
Third-party followed by donor-derived Viremia improved from 500 292 to 54 891 copies per mL after first infusion, then to 863 copies per mL after second infusion 
Third-party Viremia decreased from 3140 to <1000 copies per mL with improvement in adenoviral diarrhea 
Third-party No viremia; reduction but not resolution of adenoviral diarrhea 
Donor-derived Viremia worsened from 4694 to 8103 copies per mL after first infusion but decreased to 810 copies per mL after second infusion 
Patient with PRThird-party or donor-derived VSTNo. of infusionsDetails of PR
Third-party Viremia improved from 4400 to <100 copies per mL 
Third-party Viremia improved from 1 million to 7135 copies per mL after first infusion; no further decrease with second infusion 
Third-party followed by donor-derived Viremia improved from 500 292 to 54 891 copies per mL after first infusion, then to 863 copies per mL after second infusion 
Third-party Viremia decreased from 3140 to <1000 copies per mL with improvement in adenoviral diarrhea 
Third-party No viremia; reduction but not resolution of adenoviral diarrhea 
Donor-derived Viremia worsened from 4694 to 8103 copies per mL after first infusion but decreased to 810 copies per mL after second infusion 
Close Modal

or Create an Account

Close Modal
Close Modal